Announcements Trials
Browse Landscape

Status

Completed 3Recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 11Observational 3

Sponsor

Cancer Type

CNS 3

Conditions

Breast Neoplasms 1388Neoplasms 1168Colorectal Neoplasms 626Lung Neoplasms 562Prostatic Neoplasms 538Carcinoma, Non-Small-Cell Lung 444Carcinoma, Hepatocellular 296Stomach Neoplasms 272Pancreatic Neoplasms 270Colonic Neoplasms 264Ovarian Neoplasms 231Head and Neck Neoplasms 228Rectal Neoplasms 221Melanoma 216Multiple Myeloma 204Uterine Cervical Neoplasms 198Lymphoma 195Leukemia 193Precursor Cell Lymphoblastic Leukemia-Lymphoma 191Neoplasm Metastasis 178Carcinoma, Renal Cell 177Brain Neoplasms 174Esophageal Neoplasms 173Leukemia, Myeloid, Acute 158Urinary Bladder Neoplasms 138Recurrence 123Polycystic Ovary Syndrome 122Liver Neoplasms 119Hematologic Neoplasms 117Endometrial Neoplasms 107

Interventions

gadobenic acid 2gadoteridol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Observational × Central Nervous System Diseases × Clear all
NCT03750188 2020-01-23

Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrs

Bracco Diagnostics, Inc

Completed
125 enrolled
CNS

Central Nervous System Diseases, Central Nervous System Neoplasms

NCT03147989 2018-07-18

Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients

Bracco Diagnostics, Inc

Completed
352 enrolled
CNS

Central Nervous System Diseases, Central Nervous System Neoplasms

NCT02291822 2016-07-19

Retrospective Study of MRI in Pediatric Patients

Bracco Diagnostics, Inc

Completed
90 enrolled
CNS

Central Nervous System Diseases, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡